Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. The firm is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Follow-Up Questions
Haemonetics Corp (HAE)'in P/E oranı nedir?
Haemonetics Corp 'in P/E oranı 14.1217 'dir
Haemonetics Corp 'in CEO'su kimdir?
Mr. Christopher Simon 2016 'den beri şirketle birlikte olan Haemonetics Corp 'in President 'ıdır.
HAE hissesinin fiyat performansı nasıl?
HAE 'in mevcut fiyatı $50.7 'dir, son işlem günde 0.64% increased etti.
Haemonetics Corp için ana iş temaları veya sektörler nelerdir?
Haemonetics Corp Health Care endüstrisine ait ve sektör Health Care 'dir
Haemonetics Corp 'in piyasa değerlemesi nedir?
Haemonetics Corp 'in mevcut piyasa değerlemesi $2.4B 'dir
Haemonetics Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 12 analist Haemonetics Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 5 güçlü al, 7 al, 2 tut, 1 sat ve 5 güçlü sat içermektedir
